BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26167620)

  • 1. Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.
    Porter M; Davies MA; Mapani MK; Rabie H; Phiri S; Nuttall J; Fairlie L; Technau KG; Stinson K; Wood R; Wellington M; Haas AD; Giddy J; Tanser F; Eley B
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):593-601. PubMed ID: 26167620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017.
    Iyun V; Technau KG; Eley B; Rabie H; Boulle A; Fatti G; Egger M; Tanser F; Wood R; Fairlie L; Cotton MF; Davies MA
    Pediatr Infect Dis J; 2020 Feb; 39(2):127-133. PubMed ID: 31725119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
    Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA;
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa.
    Nglazi MD; Lawn SD; Kaplan R; Kranzer K; Orrell C; Wood R; Bekker LG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):e1-8. PubMed ID: 21084996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
    Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA;
    PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes among HIV-positive orphaned and non-orphaned children on antiretroviral therapy in Johannesburg, South Africa.
    Hendrickson C; Evans D; Brennan AT; Patz S; Untiedt S; Bassett J; Levin L; Sanne I; Fox MP
    S Afr Med J; 2019 Aug; 109(9):679-685. PubMed ID: 31635594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
    Fatti G; Mothibi E; Meintjes G; Grimwood A
    PLoS One; 2014; 9(6):e100273. PubMed ID: 24949879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment.
    Yotebieng M; Van Rie A; Moultrie H; Cole SR; Adimora A; Behets F; Meyers T
    AIDS; 2010 Jun; 24(9):1341-9. PubMed ID: 20559039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration.
    Davies MA; Phiri S; Wood R; Wellington M; Cox V; Bolton-Moore C; Timmerman V; Moultrie H; Ndirangu J; Rabie H; Technau K; Giddy J; Maxwell N; Boulle A; Keiser O; Egger M; Eley B;
    PLoS One; 2013; 8(12):e81037. PubMed ID: 24363808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth in HIV-infected children on long-term antiretroviral therapy.
    Feucht UD; Van Bruwaene L; Becker PJ; Kruger M
    Trop Med Int Health; 2016 May; 21(5):619-29. PubMed ID: 26914715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
    Innes S; Lazarus E; Otwombe K; Liberty A; Germanus R; Van Rensburg AJ; Grobbelaar N; Hurter T; Eley B; Violari A; Cotton MF
    J Int AIDS Soc; 2014; 17(1):18914. PubMed ID: 24925044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
    Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
    J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa.
    Nglazi MD; Kranzer K; Holele P; Kaplan R; Mark D; Jaspan H; Lawn SD; Wood R; Bekker LG
    BMC Infect Dis; 2012 Jan; 12():21. PubMed ID: 22273267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.